Список літератури, представлений в прототипі клінічної настанови 1 страница

The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiolody. Guidelines for the management of arterial hypertension. European Heart Journal, 2007.

1. Guidelines Sub-Committee. 1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organization/Inter­national Society of Hypertension meeting. J Hypertens 1993;11: 905–918. GL.

2. Guidelines Sub-Committee. 1999 World Health Organization/Inter­national Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999;17:151–183. GL.

3. Guidelines Committee 2003. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011–1053. GL.

4. Top 10 papers published. The Scientist 2005;19:26. OS.

5. ESH/ESC Hypertension Practice Guidelines Committee. Practice guide­lines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens 2003;21:1779–1786. GL.

6. Simoons ML, van der Putten N, Wood D, Boersma E, Bassand JP. The Cardiology Information System: the need for data standards for inte­gration of systems for patient care, registries and guidelines for clinical practice. Eur Heart J 2002;23:1148–1152. GL.

7. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure stroke coronary heart disease. Part 1 prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765–774. MA.

8. Report of the Joint National Committee on Detection Evaluation. Treat­ment of High Blood Pressure: a cooperative study. JAMA 1977;237: 255–261. GL.

9. The 1980 report of the Joint National Committee on Detection, Evalu­ation, and Treatment of High Blood Pressure. Arch Intern Med 1980; 140:1280–1285. GL.

10. Collins R, Peto R, MacMahon S, Herbert P, Fieback NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure stroke coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990;335:827–839. MA.

11. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360: 1903–1913. MA.

12. European cardiovascular disease statistics, British Heart Foundation 2000 www.dphpc.ox.ac/UKbhfhprg. RV.

13. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996;275:1571–1576. OS.

14. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996;275:1557–1562. OS.

15. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381–386. OS.

16. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13–18. OS.

17. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005;365:217–223. OS.

18. Martiniuk AL, Lee CM, Lawes CM, Ueshima H, Suh I, Lam TH, Gu D, Feigin V, Jamrozik K, Ohkubo T, Woodward M, for the Asia-Pacific Cohort Studies Collaboration. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens 2007;25:73–79. OS.

19. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003;289:2363–2369. OS.

20. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ, Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347–1360. RV.

21. Franklin SS. Ageing and hypertension: the assessment of blood pressure indices in predicting coronary heart disease. J Hypertens 1999;17(Suppl 5):S29–S36. RV.

22. Benetos A, Zureik M, Morcet J, Thomas F, Bean K, Safar M, Ducimetiere P, Guize L. A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with a higher cardiovascular mortality in men. J Am Coll Cardiol 2000;35: 673–680. OS.

23. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, Boissel JP, Coope J, Ekbom T, Gueyffier F, Liu L, Kerlikowske K, Pocock S, Fagard RH. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000;355: 865–872. MA.

24. Darne B, Girerd X, Safar M, Cambien F, Guize L. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospec­tive analysis on cardiovascular mortality. Hypertension 1989;13: 392–400. OS.

25. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetieere P, Guize L. Pulse pressure: a predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997;30: 1410–1415. OS.

26. Gasowski J, Fagard RH, Staessen JA, Grodzicki T, Pocock S, Boutitie F, Gueyffier F, Boissel JP, INDANA Project Collaborators. Pulsatile blood pressure component as predictor of mortality in hypertension: a meta-analysis of clinical trial control groups. J Hypertens 2002;20: 145–151. MA.

27. Blacher J, Staessen JA, Girerd X, Gasowski J, Thijs L, Liu L, Wang JG, Fagard RH, Safar ME. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000;160:1085–1089. MA.

28. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, Pannier B, Vlachopoulos C, Wilkinson I, Struijker-Boudier H. on behalf of the European Network for non invasive investigation of large arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27: 2588–2605. GL.

29. Pickering G. The nature of essential hypertension. J & A. Churchill Ltd, London 1961; 1–151. RV.

30. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo L Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, National Heart, Lung, Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206–1252. GL.

31. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D’Agostino RB, Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002;287:1003–1010. OS.

32. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of fre­quency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358: 1682–1686. OS.

33. Vasan RS, Larson MG, Leip EP, Evans JC, O’Donnell CJ, Kannel WB, Levy D. Impact of high-normal blood pressure on the risk of cardiovascu­lar disease. N Engl J Med 2001;345:1291–1297. OS.

34. Mancia G, Grassi G. European, American and British Guidelines: simi­larities and differences. In: Black HR, Elliott WJ, editors. Hypertension. A companion to Braunwald’s Heart diseases. Amsterdam: Saunders-Elsevier; 2007. pp. 571–575.

35. Kannel WB. Risk stratification in hypertension: new insights from the Framingham Study. Am J Hypertens 2000;13(Suppl 1):S3–S10. OS.

36. Thomas F, Rudnichi A, Bacri AM, Bean K, Guize L, Benetos A. Cardiovas­cular mortality in hypertensive men according to presence of associated risk factors. Hypertension 2001;37:1256–1261. OS.

37. Wei M, Mitchell BD, Haffner SM, Stern MP. Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol 1996;144:1058–1065. OS.

38. Assmann G, Schulte H. The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hyper­tension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 1988;116:1713–1724. OS.

39. Mancia G, Parati G, Borghi C, Ghironzi G, Andriani E, Marinelli L, Valentini M, Tessari F, Ambrosioni E. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens 2006;24: 837–843. OS.

40. Mancia G, Facchetti R, Bombelli M, Friz HP, Grassi G, Giannattasio C, Sega R. Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hyperten­sion 2005;45:1072–1077. OS.

41. Asia Pacific Cohort Studies Collaboration. Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region. Circulation 2005;112:3384–3390. OS.

42. Multiple Risk Factor Intervention Trial Research Group Relationship between baseline risk factors coronary heart disease total mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Inter­vention Trial Research Group. Prev Med 1986;15:254–273. OS.

43. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens 1998;16: 1407–1414. GL.

44. De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D. European guidelines on cardio­vascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601–1610. GL.

45. D’Agostino RBS, Grundy S, Sullivan LM, Wilson P. Validation of the Fra-mingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001;286:180–187. OS.

46. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM. Estimation of ten-year risk of fatal cardiovas­cular disease in Europe: the SCORE project. Eur Heart J 2003;24: 987–1003. OS.

47. World Health Organization/International Society of Hypertension. 2003. World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21: 1983–1992. GL.

48. Evans JG, Rose G. Hypertension. Br Med Bull 1971;27:37–42. RV.

49. Executive Summary of the Third Report of the National Cholesterol Edu­cation Program (NCEP) Expert Panel on Detection Evaluation. Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Expert Panel on Detection Evaluation Treatment of High Blood Cholesterol in Adults. JAMA 2001;285:2486–2497. GL.

50. Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson W. The cardiovascular disease continuum vali­dated: clinical evidence of improved patient outcomes: part I: Patho-physiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation 2006;114:2850–2870. RV.

51. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31–41.

52. Hallan S, Asberg A, Lindberg M, Johnsen H. Validation of the Modifi­cation of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 2004;44:84–93.

53. Olsen MH, Wachtell K, Bella JN, Palmieri V, Gerdts E, Smith G, Nieminen MS, Dahlof B, Ibsen H, Devereux RB. Albuminuria predicts cardiovascular events independently of left ventricular mass in hyper­tension: a LIFE substudy. J Hum Hypertens 2004;18:453–459. OS.

54. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113:664–670. OS.

55. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001;37:1236–1241. OS.

56. Feringa HH, Bax JJ, van Waning VH, Boersma E, Elhendy A, Schouten O, Tangelder MJ, van Sambeek MH, van den Meiracker AH, Poldermans D. The long-term prognostic value of the resting and postexercise ankle-brachial index. Arch Intern Med 2006;166:529–535. OS.

57. Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlof B. Prognostic significance of left ventricular mass change during treatment of hyper­tension. JAMA 2004;292:2350–2356. OS.

58. Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y. Reduction in albuminuria translates to reduction in cardiovascu­lar events in hypertensive patients: Losartan Intervention For Endpoint reduction in hypertension study. Hypertension 2005;45:198–202. OS.

59. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM. Albuminuria, a Thera­peutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy. Circulation 2004;110:921–927. OS.

60. Olsen MH, Wachtell K, Ibsen H, Lindholm LH, Dahlof B, Devereux RB, Kjeldsen SE, Oikarinen L, Okin PM. LIFE Study Investigators. Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study. J Hypertens 2006;24:775–781. OS.

61. Verdecchia P, Angeli F, Borgioni C, Gattobigio R, de Simone G, Devereux RB, Porcellati C. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hyper-tens 2003;16:895–899. MA.

62. Benetos A, Rudnichi A, Thomas F, Safar M, Guize L. Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. Hypertension 1999;33:44–52. OS.

63. Palatini P, Thijs L, Staessen JA, Fagard RH, Bulpitt CJ, Clement DL, de Leeuw PW, Jaaskivi M, Leonetti G, Nachev C, O’Brien ET, Parati G, Rodicio JL, Roman E, Sarti C, Tuomilehto J, Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Predictive value of clinic, ambula­tory heart rate for mortality in elderly subjects with systolic hyper­tension. Arch Intern Med 2002;162:2313–2321. OS.

64. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham study. Am Heart J 1987; 113:1489–1494. OS.

65. Palatini P, Benetos A, Grassi G, Julius S, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Pessina AC, Ruilope LM, Zanchetti A. European Society of Hypertension Identification and management of the hyper­tensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006;24: 603–610. GL.

66. Levy RL, White PD, Stroud WD, Hillman CC. Transient tachycardia: prog­nostic significance alone and in association with transient hypertension. JAMA 1945;129:585–588. OS.

67. King DE, Everett CJ, Mainous AG 3rd, Liszka HA. Long-term prognostic value of resting heart rate in subjects with prehypertension. Am J Hypertens 2006;19:796–800. OS.

68. Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S. Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension 1997;30:1267–1273. OS.

69. ManciaG, Bombelli M, Corrao G, Facchetti R, Madotto F, Giannattasio C, Trevano FQ, Grassi G, Zanchetti A, Sega R. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 2007;49:40–47. OS.

70. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937–952. OS.

71. Fourth Joint Task Force of European, other Societies on Cardiovascular Disease Prevention in Clinical Practice. European Guidelines on cardio­vascular disease prevention in clinical practice. Eur Heart J 2007: in preparation. GL.

72. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, di Rienzo M, Pedotti A, Zanchetti A. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983;53:96–104. OS.

73. Sega R, Cesana G, Bombelli M, Grassi G, Stella ML, Zanchetti A, Mancia G. Seasonal variations in home and ambulatory blood pressure in the PAMELA population. Pressione Arteriose Monitorate E Loro Asso-ciazioni. J Hypertens 1998;16:1585–1592. OS.

74. Modesti PA, Morabito M, Bertolozzi I, Massetti L, Panci G, Lumachi C, Giglio A, Bilo G, Caldara G, Lonati L, Orlandini S, Maracchi G, Mancia G, Gensini GF, Parati G. Weather-related changes in 24-hour blood pressure profile: effects of age and implications for hypertension management. Hypertension 2006;47:155–161. OS.

75. O’Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G, Mengden T, Myers M, Padfield P, Palatini P, Parati G, Pickering T, Redon J, Staessen J, Stergiou G, Verdecchia P. European Society of Hypertension Recommendations for Conventional, Ambulatory and Home Blood Pressure Measurement. J Hypertens 2003;21:821–848. GL.

76. O’Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hyper­tension. Br Med J 2001;322:531–536. GL.

77. Mancia G, Omboni S, Parati G, Clement DL, Haley WE, Rahman SN, Hoogma RP. Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study. J Hypertens 2001;19: 1755–1763. OS.

78. Mancia G, Omboni S, Ravogli A, Parati G, Zanchetti A. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment: additional information from a large data base. Blood Press 1995;4: 148–156. OS.

79. Mancia G, Parati G, Bilo G, Maronati A, Omboni S, Hennig M, Zanchetti A. Assessment of long-term antihypertensive treatment by clinic an ambulatory blood pressure. Data from the ELSA Study. J Hypertens 2007;25:1087–1094. OS.

80. Fagard RH, Staessen JA, Thijs L. Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy. J Hypertens 1997;15:1493–1502. OS.

81. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, Pessina A, Porcellati C, Rappelli A, Salvetti A, Trimarco B. Ambulatory blood pressure is superior to clinic blood pressure in pre­dicting treatment induced regression of left ventricular hypertrophy. Circulation 1997;95:1464–1470. OS.

82. Fagard RH, Staessen JA, Thijs L. Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hyperten­sion 1997;29:22–29. OS.

83. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C. Circadian blood pressure changes and left ventri­cular hypertrophy in essential hypertension. Circulation 1990;81: 528–536. OS.

84. Mancia G, Parati G, Hennig M, Flatau B, Omboni S, Glavina F, Costa B, Scherz R, Bond G, Zanchetti A. Relation between blood pressure varia­bility and carotid artery damage in hypertension: baseline data from European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2001;19:1981–1989. OS.

85. Redon J, Baldo E, Lurbe E, Bertolin V, Lozano JV, Miralles A, Pascual JM. Microalbuminuria, left ventricular mass and ambulatory blood pressure in essential hypertension. Kidney Int Suppl 1996;55:S81–S84. OS.

86. Imai Y, Ohkubo T, Sakuma M, Tsuji II, Satoh H, Nagai K, Hisamichi S, Abe K. Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: a prospective observation in a cohort from Ohasama, Northern Japan. Blood Press Monit 1996;1:251–254. OS.

87. Staessen JA, Thijs L, Fagard R, O’Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J. Pre­dicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999;282: 539–546. OS.

88. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, Gheeraert PJ, Missault LH, Braun JJ, Six RO, Van Der

89. Niepen P, O’Brien E. Prognostic value of ambulatory blood pressure recordings in patients with treated hypertension. New Engl J Med 2003;348:2407–2415. OS.

90. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G. Prognostic value of ambulatory and home blood pressure com­pared with office blood pressure in the general population: follow-up results from the PAMELA study. Circulation 2005;111:1777–1783. OS.

91. Fagard RH, Celis H. Prognostic significance of various characteristics of out-of-the-office blood pressure. J Hypertens 2004;22:1663–1666. OS.

92. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O’Brien E. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality. Hyperten­sion 2005;46:156–161. OS.

93. Fagard RH, Van Den Broeke C, De Cort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory moni­toring in older patients in general practice. J Hum Hypertens 2005;19: 801–807. OS.

94. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambu­latory blood pressure and mortality. A population-based study. Hyper­tension 2005;45:499–504. OS.

95. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mor­tality. The Ohasama Study. Hypertension 2005;45:240–245. OS.

96. Pickering TG, Shimbo D, Haas D. Ambulatory blood pressure monitoring. New Engl J Med 2006;354:2368–2374. RV.

97. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension 1998;31:712–718. OS.

98. Coats AJS, Radaelli A, Clark SJ, Conway J, Sleight P. The influence of ambulatory blood pressure monitoring on the design and interpretation of trials in hypertension. J Hypertension 1992;10:385–391. OS.

99. Mancia G, Ulian L, Parati G, Trazzi S. Increase in blood pressure repro-ducibility by repeated semi-automatic blood pressure measurements in the clinic environment. J Hypertens 1994;12:469–473. OS.

100. Parati G, Pomidossi G, Casadei V, Mancia G. Lack of alerting reactions and pressor responses to intermittent cuff inflations during non-invasive blood pressure monitoring. Hypertension 1985;7:597–601. OS.

101. Mancia G, Omboni S, Parati G, Ravogli A, Villani A, Zanchetti A. Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 1995;8: 311–315. OS.

102. Staessen JA, Thijs L, Clement D, Davidson C, Fagard R, Lehtonen A, Mancia G, Palatini P, O’Brien ET, Parati G, Webster J, Amery A. Ambula­tory blood pressure decreases on long-term placebo treatment in older patients with isolated systolic hypertension. J Hypertens 1994;12: 1035–1039. OS.

103. O’Brien E, Sheridan J, O’Malley K. Dippers and non-dippers. Lancet 1988;2:397. RV.

104. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002;20:2183–2189. OS.

105. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A. Ambulatory blood pressure. An independent predictor of prognosis in essential hyperten­sion. Hypertension 1994;24:793–801. OS.

106. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline, The Ohasama Study. Hypertension 2006;47:149–154. OS.

107. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambu­latory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens 2006;19:243–250. OS.

108. Willich SN, Goldberg RJ, Maclure M, Perriello L, Muller JE. Increased onset of sudden cardiac death in the first three hours after awakening. Am J Cardiol 1992;70:65–68. OS.

109. Rocco MB, Barry J, Campbell S, Nabel E, Cook EF, Goldman L, Selwyn AP. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987;75:395–400. OS.

110. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, Poole WK, Passamani E, Roberts R, Robertson T. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315–1322. OS.

111. Elliott WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke 1998;29:992–996. MA.

112. Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood-pressure. Lancet 1978;1:795–797. OS.

113. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003;107: 1401–1406. OS.

114. Mancia G, Zanchetti A. Cardiovascular regulation during sleep. In: Orem J. editor Handbook of Physiology during Sleep. New York: Academic Press; 1980. pp. 1–55. RV.

115. El-Tamimi H, Mansour M, Pepine CJ, Wargovich TJ, Chen H. Circadian variation in coronary tone in patients with stable angina. Protective role of the endothelium. Circulation 1995;92:3201–3205. OS.

116. Otto ME, Svatikova A, Barretto RB, Santos S, Hoffmann M, Khandheria B, Somers V. Early morning attenuation of endothelial function in healthy humans. Circulation 2004;109:2507–2510. OS.

117. Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE. Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension 1998;32:965–971. OS.

118. Weber MA. The 24-hour blood pressure pattern: does it have impli­cations for morbidity and mortality? Am J Cardiol 2002;89:27A–33A. RV.

119. Undar L, Turkay C, Korkmaz L. Circadian variation in circulating platelet aggregates. Ann Med 1989;21:429–433. OS.

120. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993;11:1133–1137. OS.

121. Sander D, Kukla C, Klingelhofer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study. Circulation 2000; 102:1536–1541. OS.

122. Verdecchia P, Borgioni C, Ciucci A, Gattobigio R, Schillaci G, Sacchi N, Santucci A, Santucci C, Reboldi G, Porcellati C. Prognostic significance of blood pressure variability in essential hypertension. Blood Press Monit 1996;1:3–11. OS.

123. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Quarti-Trevano F, Grassi G, Sega R. Long term prognostic value of blood pressure variability in the general population: result of the PAMELA study. Hypertension 2007; in press. OS.

124. Staessen J, Fagard RH, Lijnen PJ, Van Hoof R, Amery AK. Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies. Am J Cardiol 1991;67:723–727. MA.

125. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, Zanchetti A. Ambulatory blood pressure normality: results from the PAMELA Study. J Hypertens 1995;13:1377–1390. OS.

126. Ohkubo T, Imai Y, Tsuji I, Nagai K, Ito S, Satoh H, Hisamichi S. Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion: the Ohasama Study. Hypertension 1998;32: 255–259. OS.

127. Sakuma M, Imai Y, Nagai K, Watanabe N, Sakuma H, Minami N, Satoh H, Abe K. Reproducibility of home blood pressure measurements over a 1-year period. Am J Hypertens 1997;10:798–803. OS.